Chronic nicotinamide riboside supplementation is well-Tolerated and elevates NAD+ in healthy middle-Aged and older adults

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Martens, Christopher R ^a   Denman, Blair A ^a   Mazzo, Melissa R ^a   Armstrong, Michael L ^b   Reisdorph, Nichole ^b   McQueen, Matthew B ^a   Chonchol, Michel ^b   Seals, Douglas R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE RIBOSIDE; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINAMIDE-BETA-RIBOSIDE;

BIOAVAILABILITY; BLOOD; CARDIOVASCULAR SYSTEM; ENZYME; ENZYME ACTIVITY; METABOLISM; PH; PHYSIOLOGY;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CAROTID ARTERY PULSE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE TOLERANCE; FEMALE; FEMORAL ARTERY; HOT FLUSH; HUMAN; INCREASED BRUISING; LEG CRAMP; MALE; METABOLOME; MIDDLE AGED; NAUSEA; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PULSE PRESSURE; PULSE WAVE; PURINE METABOLISM; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD PRESSURE; CALORIC RESTRICTION; DRUG EFFECT; METABOLISM; PROCEDURES;

AGED; BLOOD PRESSURE; CALORIC RESTRICTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NAD; NIACINAMIDE; VASCULAR STIFFNESS;

EID: 85044618726     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-03421-7     Document Type: Article

References (83)

1. Mozaffarian, D. et al. Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 133, E38-E360 (2016).
2. Lakatta, E. G. & Levy, D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises Part I: Aging arteries: A "set up" for vascular disease. Circulation 107, 139-146 (2003).
3. Donato, A. J. et al. Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell 12, 772-783 (2013).
4. Young, J. B., FAU - Mullen, D., Mullen, D., FAU - Landsberg, L. & Landsberg, L. Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. Metabolism 27, 1711-1714 (1978).
5. Pierce, G. L. et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension 52, 72-79 (2008).
6. Dengo, A. L. et al Arterial destiffening with weight loss in overweight and obese middle-Aged and older adults. Hypertension 55, 855-861 (2010).
7. King, D. E., Mainous, A. G. III, Carnemolla, M. & Everett, C. J. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am. J. Med. 122, 528-534 (2009).
8. Villareal, D. T. et al Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: A randomized clinical trial. J. Bone Miner. Res. 31, 40-51 (2016).
9. Miller, S. L. & Wolfe, R. R. The danger of weight loss in the elderly. J. Nutr. Health Aging 12, 487-491 (2008).
10. Martens, C. R. & Deals, D. R. Practical alternatives to chronic caloric restriction for optimizing vascular function with aging. J. Physiol. 594, 7177-7195 (2016).
11. Chung, K. W. et al. Recent advances in calorie restriction research on aging. Exp. Gerontol. 48, 1049-1053 (2013).
12. Ingram, D. K. et al. Calorie restriction mimetics: An emerging research field. Aging Cell 5, 97-108 (2006).
13. Mouchiroud, L., Houtkooper, R. H. & Auwerx, J. NAD(+) metabolism: A therapeutic target for age-related metabolic disease. Crit. Rev. Biochem. Mol. Biol. 48, 397-408 (2013).
14. Lin, S., Defossez, P. & Guarente, L. Requirement of NAD and SIR2 for lifespan extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126-2128 (2000).
15. Donato, A. J. et al. SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J. Physiol. 589, 4545-4554 (2011).
16. Chen, D. et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 22, 1753-1757 (2008).
17. Canto, C. et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise.
18. Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-And ageinduced diabetes in mice. Cell Metab. 14, 528-536 (2011).
19. Massudi, H. et al. Age-Associated changes in oxidative stress and NAD(+) metabolism in human tissue. PLoS ONE 7, e42357 (2012).
20. Gomes, A. P. et al Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624-1638 (2013).
21. Zhu, X., Lu, M., Lee, B., Ugurbil, K. & Chen, W. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc. Natl. Acad. Sci. USA 112, 2876-2881 (2015).
22. Bogan, K. L. & Brenner, C. Nicotinic acid nicotinamide and nicotinamide riboside: A molecular evaluation of NAD(+) precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115-130 (2008).
23. MacKay, D., Hathcock, J. & Guarneri, E. Niacin: chemical forms, bioavailability, and health effects. Nutr. Rev. 70, 357-366 (2012).
24. Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M. & Sinclair, D. A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1. J. Biol. Chem. 277, 45099-45107 (2002).
25. Guan, X., Lin, P., Chakrabarti, R. & Knoll, E. Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: computational and experimental studies. PLoS One. 9, e107729 (2014).
26. Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).
27. Mills, K. F. et al. Long-Term administration of nicotinamide mononucleotide mitigates age-Associated physiological decline in mice. Cell Metab. 24, 795-806 (2016).
28. Frederick, D. W. et al. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab. 24, 269-282 (2016).
29. de Picciotto, N. E. et al. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell 15, 522-530 (2016).
30. Sato, S. et al. Circadian reprogramming in the liver identifies metabolic pathways of aging. Cell 170, 664-66 (2017).
31. Chi, Y. & Sauve, A. A. Nicotinamide riboside, a trace nutrient in foods, is a Vitamin B3 with effects on energy metabolism and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 16, 657-661 (2013).
32. Imai, S. A possibility of nutriceuticals as an anti-Aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol. Res. 62, 42-47 (2010).
33. Ratajczak, J. et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun. 7, 13103 (2016).
34. Trammell, S. A. & Brenner, C. Targeted, LCMS-based metabolomics for quantitative measurement of NAD+ metabolites. Comput. Struct. Biotechnol. J. 4, e201301012 (2013).
35. Houtkooper, R. H., Canto, C., Wanders, R. J. & Auwerx, J. The secret life of NAD(+): An old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 31, 194-223 (2010).
36. Chobanian, A. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure-The JNC 7 report. JAMA-J. Am. Med. Assoc. 289, 2560-2572 (2003).
37. Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. https://doi.org/10.1016/j.jacc.2017.11.005 (2017).
38. Laurent, S. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27, 2588-2605 (2006).
39. Tunaru, S., Lattig, J., Kero, J., Krause, G. & Offermanns, S. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol. Pharmacol. 68, 1271-1280 (2005).
40. Benyo, Z., Gille, A., Bennett, C. L., Clausen, B. E. & Offermanns, S. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol. Pharmacol. 70, 1844-1849 (2006).
41. Carlson, L. Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review. J. Intern. Med. 258, 94-114 (2005).
42. Bieganowski, P. & Brenner, C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD(+) in fungi and humans. Cell 117, 495-502 (2004).
43. Trammell, S. A. J., Yu, L., Redpath, P., Migaud, M. E. & Brenner, C.Nicotinamide riboside is a major NAD(+) precursor vitamin in cow milk. J. Nutr. 146, 957-963 (2016).
44. Wright, J. T. Jr. et al. A randomized trial of intensive versus standard bloodpressure control. N. Engl. J. Med. 373, 2103-2116 (2015).
45. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. https://wwwn.cdc.gov/nchs/nhanes/Default.aspx(2011-2016.
46. Hardy, S. T. et al. Reducing the blood pressure-related burden of cardiovascular disease: impact of achievable improvements in blood pressure prevention and control. J. Am. Heart Assoc. 4, e002276 (2015).
47. Materson, B. J., Garcia-Estrada, M., Degraff, S. B. & Preston, R. A. Prehypertension is real and can be associated with target organ damage. J. Am. Soc. Hypertens. 11, 704-708 (2017).
48. Pase, M. P. et al. Aortic stiffness and the risk of incident mild cognitive impairment and dementia. Stroke 47, 2256-2261 (2016).
49. Chue, C. D., Townend, J. N., Steeds, R. P. & Ferro, C. J. Arterial stiffness in chronic kidney disease: causes and consequences. Heart 96, 817-823 (2010).
50. Ochi, M. et al. Arterial stiffness is associated with low thigh muscle mass in middle-Aged to elderly men. Atherosclerosis 212, 327-332 (2010).
51. Abbatecola, A. M. et al. Pulse wave velocity is associated with muscle mass decline: Health ABC study. Age 34, 469-478 (2012).
52. Mitchell, G. F. Arterial stiffness and hypertension chicken or egg? Hypertension 64, 210-214 (2014).
53. Dernellis, J. & Panaretou, M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension 45, 426-431 (2005).
54. Kaess, B. M. et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA-J. Am. Med. Assoc. 308, 875-881 (2012).
55. Mattagajasingh, I. et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 104, 14855-14860 (2007).
56. Gao, D. et al. Activation of SIRT1 attenuates Klotho deficiency-induced arterial stiffness and hypertension by enhancing AMP-Activated protein kinase activity. Hypertension 68, 1191-1199 (2016).
57. Canto, C. et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838-847 (2012).
58. Trammell, S. A. J. et al. Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice. Sci. Rep. 6, 26933 (2016).
59. Evans, C. et al NAD+metabolite levels as a function of vitamins and calorie restriction: Evidence for different mechanisms of longevity. BMC Chem. Biol. 10, 2 (2010).
60. Tanaka, H., DeSouza, C. & Seals, D. Arterial stiffness and hormone replacement use in healthy postmenopausal women. J. Gerontol. A Biol. Sci. Med. Sci. 53, M344-M346 (1998).
61. Tanaka, H., DeSouza, C. A. & Seals, D. R. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler. Thromb. Vasc. Biol. 18, 127-132 (1998).
62. Eskurza, I. et al. Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men. Am. J. Physiol. Heart Circ. Physiol. 286, H1528-H1534 (2004).
63. Moreau, K. L., Donato, A. J., Seals, D. R., DeSouza, C. A. & Tanaka, H. Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women. Cardiovasc. Res. 57, 861-868 (2003).
64. Pierce, G. L. et al. Tetrahydrobiopterin supplementation enhances carotid artery compliance in healthy older men: A pilot study. Am. J. Hypertens. 25, 1050-1054 (2012).
65. Moreau, K. L., Gavin, K. M., Plum, A. E. & Seals, D. R. Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women. Hypertension 45, 1107-1112 (2005).
66. Eskurza, I., Monahan, K. D., Robinson, J. A. & Seals, D. R. Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J. Physiol. 556, 315-324 (2004).
67. Jablonski, K. L. et al. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-Aged/older adults with moderately elevated systolic blood pressure. J. Am. Coll. Cardiol. 61, 335-343 (2013).
68. Walker, A. E., Kaplon, R. E., Pierce, G. L., Nowlan, M. J. & Seals, D. R. Prevention of age-related endothelial dysfunction by habitual aerobic exercise in healthy humans: possible role of nuclear factor kappa B. Clin. Sci. 127, 645-654 (2014).
69. Kaplon, R. E., Gano, L. B. & Seals, D. R. Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-Aged and older adults. J. Appl. Physiol. 116, 156-163 (2014).
70. Bell, C., Jones, P. P. & Seals, D. R. Oxidative stress does not modulate metabolic rate or skeletal muscle sympathetic activity with primary aging in adult humans. J. Clin. Endocrinol. Metab. 88, 4950-4954 (2003).
71. Bell, C., Stob, N. & Seals, D. Thermogenic responsiveness to beta-Adrenergic stimulation is augmented in exercising versus sedentary adults: Role of oxidative stress. J. Physiol.570, 629-635 (2006).
72. Bergman, R. N., Prager, R., Volund, A. & Olefsky, J. M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79, 790-800 (1987).
73. DeVan, A. E. et al. Regular aerobic exercise protects against impaired fasting plasma glucose-Associated vascular endothelial dysfunction with aging. Clin. Sci. 124, 325-331 (2013).
74. DeSouza, C. A. et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102, 1351-1357 (2000).
75. Reuben, D. B. et al. Motor assessment using the NIH Toolbox. Neurology 80, S65-S75 (2013).
76. Justice, J. N. et al. Improved motor and cognitive performance with sodium nitrite supplementation is related to small metabolite signatures: A pilot trial in middle-Aged and older adults. Aging 7, 1004-1021 (2015).
77. Lunsford, B. R. & Perry, J. The standing heel-rise test for ankle plantar flexion -criterion for normal. Phys. Ther. 75, 694-698 (1995).
78. Vestergaard, S. et al. Stopping to rest during a 400-meter walk and incident mobility disability in older persons with functional limitations. J. Am. Geriatr. Soc. 57, 260-265 (2009).
79. Cho, B., Scarpace, D. & Alexander, N. Tests of stepping as indicators of mobility, balance, and fall risk in balance-impaired older adults. J. Am. Geriatr. Soc. 52, 1168-1173 (2004).
80. Eriksrud, O. & Bohannon, R. W. Relationship of knee extension force to independence in sit-To-stand performance in patients receiving acute rehabilitation. Phys. Ther. 83, 544-551 (2003).
81. DeVan, A. E. et al. Effects of sodium nitrite supplementation on vascular function and related small metabolite signatures in middle-Aged and older adults. J. Appl. Physiol. 120, 416-425 (2016).
82. Kaplon, R. E. et al. Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-Aged and older adults. Aging 8, 1167-1183 (2016).
83. Peace, K. E. One-sided or two-sided p values: Which most appropriately address the question of drug efficacy? J. Biopharm. Stat. 1, 133-138 (1991).